Arcadia Biosciences, Inc. Forecast, price target & analysts
$2.92
9.24%
today
Nasdaq,
Apr 03, 06:44 pm CET
Arcadia Biosciences, Inc. Target price 2025 - Analyst rating & recommendation
Powered by
Arcadia Biosciences, Inc. Classifications & Recommendation:
Buy
100%
Arcadia Biosciences, Inc. Price Target
| Target Price | $12.00 |
| Price | $2.67 |
| Potential |
348.95%
register free of charge
|
| Number of Estimates | 1 |
|
1 Analyst has issued a Arcadia Biosciences, Inc. price target 2026.
The average Arcadia Biosciences, Inc. target price is $12.00.
This is
348.95%
register free of charge
|
|
| A rating was issued by 1 analysts: 1 Analysts recommend Arcadia Biosciences, Inc. to buy, 0 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Arcadia Biosciences, Inc. stock has an average upside potential 2026 of
348.95%
register free of charge
|
Sales and Margin forecast 2025, 2026 & 2027
Create a premium account to unlock analyst estimates.
Learn more
Powered by
Quarter
Annually
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 5.05 | 6.50 |
| 13.48% | 28.71% | |
| EBITDA Margin | -96.04% | -64.62% |
| 15.03% | 32.72% |
1 Analyst has issued a sales forecast Arcadia Biosciences, Inc. 2025 . The average Arcadia Biosciences, Inc. sales estimate is
$6.5m
Unlock
22.41%
higher
Unlock
$6.5m
22.41%
Unlock
$6.5m
22.41%
Unlock
This results in the following potential growth metrics:
1 Analyst has issued an EBITDA forecast Arcadia Biosciences, Inc. 2025 . The average Arcadia Biosciences, Inc. EBITDA estimate is
$-4.2m
Unlock
35.19%
higher
Unlock
$-4.2m
35.19%
Unlock
$-4.2m
35.19%
Unlock
This results in the following potential growth metrics and future EBITDA Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027
Create a premium account to unlock analyst estimates.
Learn more
Powered by
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| EV/Sales | negative |
Current Arcadia Biosciences, Inc. Upgrades & Downgrades
Create a Premium account to unlock Upgrades/Downgrades.
Learn more
| Analyst | Rating | Action | Date |
|---|---|---|---|
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Aug 21 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Aug 21 2024 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
